NeuroPace, Inc. (NPCE) Stock Chart - Revenue & Earnings | Quarter Chart

📊 Income Statement

Revenue by Product

Revenue by Geography

Revenue, Gross Profit, Operating and Net Income

RevenueGross ProfitOperating IncomeNet Income
08M15M22M30M38M45M52M60MQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Margin (%)

Gross MarginOperating MarginNet Income Margin
01122344556687990Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Operating Expenses

Research And Development ExpensesSelling General And Administrative Expenses
04M8M11M15M19M22M26M30MQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

EBITDA

EBITDA
-8M-7M-6M-5M-4M-3M-2M-1000K1Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025

EPS

Revenue Variation (%)

Revenue Variation
-4-125811141720Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Income Variation (%)

Gross Profit VariationOperating Income Variation
0815223038455260Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Revenue YoY Variation (%)

Revenue YoY Variation
0510152025303540Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Income YoY Variation (%)

Gross Profit YoY VariationOperating Income YoY Variation
0612192531384450Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Price-to-Earning Ratio

P/E Ratio
-30-26-22-18-14-11-7-31Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Income Breakdown

Operating IncomeInterest IncomeTotal Other Income Expenses NetNet Income
0125K250K375K500K625K750K875K1MQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Per Share Metrics

Revenue Per ShareNet Income Per ShareOperating Cash Flow Per Share
000001111Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Expense Ratios

Research And Ddevelopement To RevenueCapex To RevenueStock Based Compensation To Revenue
000001111Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025
💰 Cash Flow Statement

Operating Cash Flow

Operating Cash FlowCapital ExpenditureFree Cash Flow
0250K500K750K1M1M2M2M2MQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Free Cash Flow

Cash At End Of Period
05M10M15M20M25M30M35M40MQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Cash Flow to Debt Ratio

Net Cash Provided By Operating ActivitiesNet Cash Used Provided By Financing Activities
04M8M11M15M19M22M26M30MQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025
🏦 Balance Sheet
📈 Key Metrics